Editas Historical Balance Sheet

EDIT Stock

USD 1.30 0.09 6.47%

Trend analysis of Editas Medicine balance sheet accounts such as Other Current Liabilities of 53.4 M or Total Current Liabilities of 44.6 M provides information on Editas Medicine's total assets, liabilities, and equity, which is the actual value of Editas Medicine to its prevalent stockholders. By breaking down trends over time using Editas Medicine balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Editas Medicine latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Editas Medicine is a good buy for the upcoming year.

Editas Medicine Inventory

(79.6 Million)

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Editas Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.

About Editas Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Editas Medicine at a specified time, usually calculated after every quarter, six months, or one year. Editas Medicine Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Editas Medicine and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Editas currently owns. An asset can also be divided into two categories, current and non-current.

Editas Medicine Balance Sheet Chart

At this time, Editas Medicine's Cash And Short Term Investments are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 394.2 M in 2025, whereas Net Debt is likely to drop (101.3 M) in 2025.

Total Assets Short Long Term Debt Total Total Current Liabilities Other Liab Preferred Stock Total Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Editas Medicine assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Editas Medicine books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Editas Medicine balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Editas Medicine are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Editas Medicine's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Editas Medicine current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Editas Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.At this time, Editas Medicine's Cash And Short Term Investments are comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 394.2 M in 2025, whereas Net Debt is likely to drop (101.3 M) in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	43.9M	36.5M	35.0M	35.4M
Total Assets	514.3M	499.2M	341.6M	394.2M

Short Long Term Debt Total Total Assets

Editas Medicine balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Long Term Debt
Total Assets		0.12	0.49	0.87	0.95	0.8	0.89	-0.82	-0.72	0.86	0.84	0.87	0.76	0.79	0.99	0.89	0.58	0.78	0.86	0.73	0.83	0.99	0.6	0.93	0.62	0.83
Short Long Term Debt Total	0.12		0.02	0.03	-0.12	0.11	0.04	0.19	-0.03	0.06	0.41	-0.01	0.16	0.16	0.13	0.26	0.74	-0.07	-0.02	0.6	0.03	0.16	0.07	-0.1	-0.04	0.52
Other Current Liab	0.49	0.02		0.72	0.38	0.45	0.53	-0.34	-0.9	0.56	0.37	0.43	0.5	0.75	0.43	0.69	0.4	0.33	0.7	0.54	0.65	0.48	0.18	0.57	0.0	0.47
Total Current Liabilities	0.87	0.03	0.72		0.77	0.75	0.93	-0.77	-0.87	0.9	0.75	0.75	0.71	0.8	0.82	0.94	0.54	0.61	0.94	0.74	0.94	0.86	0.58	0.9	0.56	0.81
Total Stockholder Equity	0.95	-0.12	0.38	0.77		0.64	0.83	-0.8	-0.66	0.81	0.68	0.93	0.75	0.75	0.93	0.77	0.3	0.82	0.84	0.47	0.78	0.9	0.49	0.93	0.57	0.64
Other Liab	0.8	0.11	0.45	0.75	0.64		0.73	-0.78	-0.5	0.67	0.78	0.45	0.37	0.41	0.81	0.67	0.74	0.5	0.58	0.82	0.59	0.87	0.77	0.65	0.7	0.73
Property Plant And Equipment Net	0.89	0.04	0.53	0.93	0.83	0.73		-0.83	-0.78	0.93	0.8	0.78	0.72	0.74	0.86	0.89	0.49	0.54	0.88	0.68	0.96	0.88	0.72	0.89	0.65	0.85
Net Debt	-0.82	0.19	-0.34	-0.77	-0.8	-0.78	-0.83		0.53	-0.71	-0.82	-0.6	-0.4	-0.51	-0.82	-0.65	-0.36	-0.53	-0.66	-0.53	-0.71	-0.84	-0.81	-0.8	-0.84	-0.66
Retained Earnings	-0.72	-0.03	-0.9	-0.87	-0.66	-0.5	-0.78	0.53		-0.79	-0.54	-0.72	-0.78	-0.92	-0.66	-0.89	-0.39	-0.51	-0.92	-0.58	-0.89	-0.68	-0.31	-0.82	-0.18	-0.65
Accounts Payable	0.86	0.06	0.56	0.9	0.81	0.67	0.93	-0.71	-0.79		0.7	0.84	0.75	0.74	0.81	0.89	0.47	0.6	0.88	0.65	0.92	0.82	0.56	0.83	0.54	0.77
Cash	0.84	0.41	0.37	0.75	0.68	0.78	0.8	-0.82	-0.54	0.7		0.57	0.48	0.59	0.85	0.77	0.77	0.47	0.62	0.85	0.69	0.89	0.77	0.69	0.74	0.92
Non Current Assets Total	0.87	-0.01	0.43	0.75	0.93	0.45	0.78	-0.6	-0.72	0.84	0.57		0.84	0.83	0.83	0.8	0.25	0.84	0.86	0.43	0.79	0.78	0.25	0.88	0.38	0.61
Non Currrent Assets Other	0.76	0.16	0.5	0.71	0.75	0.37	0.72	-0.4	-0.78	0.75	0.48	0.84		0.84	0.69	0.85	0.34	0.6	0.86	0.49	0.8	0.68	0.23	0.8	0.18	0.65
Other Assets	0.79	0.16	0.75	0.8	0.75	0.41	0.74	-0.51	-0.92	0.74	0.59	0.83	0.84		0.75	0.88	0.4	0.67	0.89	0.56	0.83	0.73	0.21	0.86	0.18	0.68
Cash And Short Term Investments	0.99	0.13	0.43	0.82	0.93	0.81	0.86	-0.82	-0.66	0.81	0.85	0.83	0.69	0.75		0.84	0.6	0.79	0.81	0.73	0.77	0.98	0.6	0.9	0.63	0.81
Common Stock Shares Outstanding	0.89	0.26	0.69	0.94	0.77	0.67	0.89	-0.65	-0.89	0.89	0.77	0.8	0.85	0.88	0.84		0.63	0.61	0.94	0.79	0.93	0.87	0.49	0.89	0.42	0.88
Non Current Liabilities Total	0.58	0.74	0.4	0.54	0.3	0.74	0.49	-0.36	-0.39	0.47	0.77	0.25	0.34	0.4	0.6	0.63		0.26	0.38	0.97	0.41	0.67	0.54	0.36	0.39	0.82
Other Current Assets	0.78	-0.07	0.33	0.61	0.82	0.5	0.54	-0.53	-0.51	0.6	0.47	0.84	0.6	0.67	0.79	0.61	0.26		0.66	0.4	0.5	0.71	0.13	0.76	0.44	0.46
Other Stockholder Equity	0.86	-0.02	0.7	0.94	0.84	0.58	0.88	-0.66	-0.92	0.88	0.62	0.86	0.86	0.89	0.81	0.94	0.38	0.66		0.59	0.96	0.81	0.38	0.95	0.35	0.72
Total Liab	0.73	0.6	0.54	0.74	0.47	0.82	0.68	-0.53	-0.58	0.65	0.85	0.43	0.49	0.56	0.73	0.79	0.97	0.4	0.59		0.62	0.8	0.61	0.56	0.49	0.91
Property Plant And Equipment Gross	0.83	0.03	0.65	0.94	0.78	0.59	0.96	-0.71	-0.89	0.92	0.69	0.79	0.8	0.83	0.77	0.93	0.41	0.5	0.96	0.62		0.8	0.54	0.9	0.44	0.79
Total Current Assets	0.99	0.16	0.48	0.86	0.9	0.87	0.88	-0.84	-0.68	0.82	0.89	0.78	0.68	0.73	0.98	0.87	0.67	0.71	0.81	0.8	0.8		0.69	0.89	0.66	0.86
Property Plant Equipment	0.6	0.07	0.18	0.58	0.49	0.77	0.72	-0.81	-0.31	0.56	0.77	0.25	0.23	0.21	0.6	0.49	0.54	0.13	0.38	0.61	0.54	0.69		0.48	0.83	0.71
Net Tangible Assets	0.93	-0.1	0.57	0.9	0.93	0.65	0.89	-0.8	-0.82	0.83	0.69	0.88	0.8	0.86	0.9	0.89	0.36	0.76	0.95	0.56	0.9	0.89	0.48		0.51	0.71
Current Deferred Revenue	0.62	-0.04	0.0	0.56	0.57	0.7	0.65	-0.84	-0.18	0.54	0.74	0.38	0.18	0.18	0.63	0.42	0.39	0.44	0.35	0.49	0.44	0.66	0.83	0.51		0.62
Long Term Debt	0.83	0.52	0.47	0.81	0.64	0.73	0.85	-0.66	-0.65	0.77	0.92	0.61	0.65	0.68	0.81	0.88	0.82	0.46	0.72	0.91	0.79	0.86	0.71	0.71	0.62

Click cells to compare fundamentals

Editas Medicine Account Relationship Matchups

Editas Medicine balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	572.6M	677.5M	514.3M	499.2M	341.6M	394.2M
Short Long Term Debt Total	26.1M	26.4M	43.9M	36.5M	35.0M	35.4M
Other Current Liab	17.2M	9.9M	20.2M	34.6M	50.9M	53.4M
Total Current Liabilities	58.2M	46.9M	60.1M	63.2M	77.2M	44.6M
Total Stockholder Equity	393.6M	553.6M	360.7M	349.1M	134.3M	232.1M
Other Liab	163.2M	101.5M	60.9M	60.7M	69.8M	71.4M
Property Plant And Equipment Net	39.1M	43.3M	59.2M	45.7M	47.1M	36.4M
Net Debt	(113.5M)	(177.1M)	(97.6M)	(87.1M)	(96.5M)	(101.3M)
Retained Earnings	(665.2M)	(857.7M)	(1.1B)	(1.2B)	(1.5B)	(1.4B)
Accounts Payable	6.4M	5.1M	9.5M	8.3M	5.5M	5.4M
Cash	139.7M	203.5M	141.5M	123.7M	131.5M	146.7M
Non Current Assets Total	153.5M	170.2M	157.6M	158.3M	52.3M	79.9M
Non Currrent Assets Other	4.7M	6.8M	5.3M	8.6M	5.2M	3.9M
Other Assets	1.7M	4.7M	6.8M	5.3M	6.0M	6.3M
Cash And Short Term Investments	511.8M	619.9M	437.4M	323.1M	269.9M	335.4M
Common Stock Shares Outstanding	58.6M	67.6M	68.7M	76.0M	82.3M	52.7M
Liabilities And Stockholders Equity	572.6M	677.5M	514.3M	499.2M	341.6M	394.2M
Non Current Liabilities Total	120.8M	77.0M	93.5M	86.8M	130.1M	117.5M
Other Current Assets	21.9M	14.4M	7.3M	7.5M	3.1M	5.9M
Other Stockholder Equity	1.1B	1.4B	1.4B	1.6B	1.6B	857.6M
Total Liab	179.0M	123.8M	153.6M	150.1M	207.3M	162.1M
Property Plant And Equipment Gross	39.1M	58.8M	80.7M	72.0M	78.7M	45.1M
Total Current Assets	419.1M	507.3M	356.8M	340.8M	289.3M	314.3M
Accumulated Other Comprehensive Income	(46K)	(493K)	(3.6M)	198K	268K	281.4K
Property Plant Equipment	39.6M	14.0M	17.1M	15.6M	17.9M	23.1M
Net Tangible Assets	262.4M	393.6M	553.6M	360.7M	414.8M	250.7M
Current Deferred Revenue	23.5M	20.9M	11.3M	8.2M	6.2M	5.9M
Net Receivables	6.0M	267K	5.1M	10.2M	16.3M	17.1M
Short Term Debt	13.6M	20.6M	22.2M	24.2M	14.7M	14.1M
Short Term Investments	262.4M	296.3M	202.8M	199.5M	138.4M	190.9M
Capital Surpluse	811.5M	1.1B	1.4B	1.4B	1.7B	854.8M
Retained Earnings Total Equity	(549.2M)	(665.2M)	(857.7M)	(1.1B)	(970.3M)	(921.8M)
Capital Lease Obligations	26.1M	26.4M	43.9M	36.5M	35.0M	36.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Editas Stock Analysis

When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Editas Historical Balance Sheet

Editas Medicine Inventory

(79.6 Million)

About Editas Balance Sheet Analysis

Editas Medicine Balance Sheet Chart

Total Assets

Total Current Liabilities

Editas Medicine balance sheet Correlations

Editas Medicine Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Editas Medicine balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Editas Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Cash And Short Term Investments
Total Liab	+ 0.97	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.96	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.96	Other Stockholder Equity

Other Stockholder Equity	- 0.92	Retained Earnings
Other Assets	- 0.92	Retained Earnings
Retained Earnings	- 0.9	Other Current Liab
Property Plant And Equipment Gross	- 0.89	Retained Earnings
Common Stock Shares Outstanding	- 0.89	Retained Earnings
Retained Earnings	- 0.87	Total Current Liabilities